These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30049461)

  • 1. Readmissions Among Patients With Peripartum Cardiomyopathy.
    Çelik O; Çil C; Biteker FS; Biteker M
    Am J Cardiol; 2018 Sep; 122(5):911. PubMed ID: 30049461
    [No Abstract]   [Full Text] [Related]  

  • 2. 12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy.
    Tak BT; Cetin EHO; Ulvan N; Cay S; Aras D
    Int J Cardiol; 2019 Oct; 293():185. PubMed ID: 31447034
    [No Abstract]   [Full Text] [Related]  

  • 3. What Should Be Generalized Diagnostic Markers for Peripartum Cardiomyopathy?
    Sakuma I; Anzai T
    Circ J; 2017 Oct; 81(11):1578-1579. PubMed ID: 29021419
    [No Abstract]   [Full Text] [Related]  

  • 4. The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy?
    Elkayam U; Habakuk O
    JACC Heart Fail; 2016 May; 4(5):389-91. PubMed ID: 27126284
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to '12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy'.
    Hoevelmann J; Viljoen CA; Millar RS; Manning K; Ntsekhe M; Sliwa K
    Int J Cardiol; 2019 Dec; 297():91. PubMed ID: 31431295
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripartum Cardiomyopathy.
    Gleicher N
    N Engl J Med; 2024 Apr; 390(15):1443. PubMed ID: 38631014
    [No Abstract]   [Full Text] [Related]  

  • 7. Devil in Disguise: Hints and Pitfalls in Diagnosis of Peripartum Cardiomyopathy.
    Bauersachs J; Koenig T
    Circ Heart Fail; 2018 Apr; 11(4):e004620. PubMed ID: 29626100
    [No Abstract]   [Full Text] [Related]  

  • 8. Peripartum Cardiomyopathy: Is It All in the Timing?
    Roth Flach RJ; Khankin EV
    Hypertension; 2020 Jan; 75(1):33-34. PubMed ID: 31707839
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripartum Cardiomyopathy. Reply.
    Arany Z
    N Engl J Med; 2024 Apr; 390(15):1443. PubMed ID: 38631015
    [No Abstract]   [Full Text] [Related]  

  • 10. Imbalanced Angiogenesis in Peripartum Cardiomyopathy (PPCM).
    Damp JA; Arany Z; Fett JD; Blauwet L; Elkayam U
    Circ J; 2018 Sep; 82(10):2689. PubMed ID: 30122728
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial commentary: Peripartum cardiomyopathy: Long-term implications of treatment and management.
    Haghikia A; Hilfiker-Kleiner D
    Trends Cardiovasc Med; 2019 Apr; 29(3):174-175. PubMed ID: 30219276
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort.
    Ersbøll AS; Arany Z; Gustafsson F
    Eur Heart J; 2018 Oct; 39(37):3476-3477. PubMed ID: 30016425
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripartum cardiomyopathy for the clinician: the known and the unknown.
    Elkayam U
    Eur J Heart Fail; 2017 Sep; 19(9):1142-1144. PubMed ID: 28653358
    [No Abstract]   [Full Text] [Related]  

  • 14. Cabergoline in the Treatment of Peripartum Cardiomyopathy.
    Fett JD
    Rev Bras Ginecol Obstet; 2016 Aug; 38(8):423-4. PubMed ID: 27583690
    [No Abstract]   [Full Text] [Related]  

  • 15. Authors' reply re: Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.
    Guldbrandt Hauge M; Johansen M; Vejlstrup N; Gustafsson F; Damm P; Ersbøll AS
    BJOG; 2018 Jul; 125(8):1040-1041. PubMed ID: 29479809
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasoinhibin Serum Levels Are Required to Demonstrate Their Role in Peripartum Cardiomyopathy Etiopathology.
    Triebel J; Clapp C; Martínez de la Escalera G; Bertsch T
    ASAIO J; 2017; 63(4):e50. PubMed ID: 28657930
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Prolactin Inhibition in the Treatment of Peripartum Cardiomyopathy.
    Fett JD
    Rev Bras Ginecol Obstet; 2016 Sep; 38(9):477-478. PubMed ID: 27658008
    [No Abstract]   [Full Text] [Related]  

  • 18. Response by Arany and Elkayam to Letter Regarding Article, "Peripartum Cardiomyopathy".
    Arany Z; Elkayam U
    Circulation; 2016 Aug; 134(7):e83-4. PubMed ID: 27528651
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter by Dalzell et al Regarding Article, "Peripartum Cardiomyopathy".
    Dalzell JR; Barton AK; McKeag NA
    Circulation; 2016 Aug; 134(7):e81-2. PubMed ID: 27528650
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.
    Hilfiker-Kleiner D; Sliwa K; Bauersachs J
    Eur Heart J; 2018 Oct; 39(37):3478. PubMed ID: 30016421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.